Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Epigenetics in Drug Discovery

Jude Fitzgibbon's Biography

Jude Fitzgibbon, Professor, Queen Mary University Of London

Jude Fitzgibbon, is Professor of Personalised Cancer Medicine at Barts and the London Medical School at QMUL with a research focus on the molecular pathogenesis of haematological malignancies. He received his BA degree in Genetics at Trinity College Dublin before completing his PhD studies at University College London and currently holds programme grant funding from Cancer Research UK and Bloodwise charities.

Jude Fitzgibbon Image

Follicular Lymphoma an Epigenetic Addicted Cancer

Wednesday, 27 January 2016 at 16:00

Add to Calendar ▼2016-01-27 16:00:002016-01-27 17:00:00Europe/LondonFollicular Lymphoma an Epigenetic Addicted CancerEpigenetics in Drug Discovery in Cambridge, UKCambridge,

Mutations in histone acety (CREBBP) and methy ltransferases (KMT2D, EZH2) are present in 80% of Follicular Lymphoma tumours. Epigenetic therapies focussing on H3K4 and K27 offer promising new approaches to treatment of this incurable disease.

Add to Calendar ▼2016-01-26 00:00:002016-01-27 00:00:00Europe/LondonEpigenetics in Drug DiscoveryEpigenetics in Drug Discovery in Cambridge, UKCambridge,